With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Generation of a novel oncolytic virus for treatment of pediatric brain tumors.||The Ohio State University / Balveen Kaur, PhD||Young Investigator Grants||2007||Ohio|
|The Identification of Neuroblastoma Cancer Stem Cells.||Stanford University / Robert Cho||Young Investigator Grants||2007||California|
|Developing an accurate genetic model for rhabdomyosarcoma therapy||Children's Research Institute / Dawn Chandler, PhD||Young Investigator Grants||2007||District of Columbia|
|The Role of Inhibition of Apoptosis by C/EBPalpha and C/EBPalpha oncoproteins in AML.||The Johns Hopkins University School of Medicine / Ido Paz-Priel, MD||Young Investigator Grants||2007||Maryland|
|Resistance to anti-angiogenic therapy in pediatric solid tumors.||Feinstein Institute for Medical Research - North Shore / Samuel Soffer, MD||Young Investigator Grants||2007||New York|
|DNA methylation in medulloblastoma||University of Colorado Denver / Rajeev Vibhakar, MD, PhD, MPH||Young Investigator Grants||2007||Colorado|
|Mechanisms of regulation of the PI#K/AKT pathway downstream of NOTCH1 in T-ALL.||Columbia University / Teresa Palomero, PhD||Young Investigator Grants||2007||New York|
|E2A translocations in pediatric leukemia: developing new therapeutic targets||Children's Hospital of Philadelphia / Bruce Fischer, MD||Young Investigator Grants||2007||Pennsylvania|
|The Role of PASG in Mediating Epigenetic Change and Outcome in AML.||The Johns Hopkins University School of Medicine / Jason Farrar, MD||Young Investigator Grants||2007||Maryland|
|Adoptive immunotherapy using clinical-grade T cells.||University of Texas M.D. Anderson Cancer Center / Laurence Cooper, MD, PhD||Innovation Grants||2007||Texas|